Sex Differences in Diabetes- and TGF-β1-Induced Renal Damage

Nadja Ziller1, Roland Kotolloshi2, Mohsen Esmaeili2

  • 1Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany.

Cells
|October 7, 2020
PubMed

Insights

Sex hormones and diabetes influence kidney damage differently in males and females. This study reveals complex interactions affecting diabetic nephropathy (DN) progression, potentially explaining conflicting research findings.

Area of Science:

  • Nephrology
  • Endocrinology
  • Genetics

Background:

  • Diabetic nephropathy (DN) shows controversial sex differences, despite females generally being less affected by non-diabetic kidney diseases.
  • Evidence suggests sex hormone imbalances in diabetes and hormone-dependent transforming growth factor β1 (TGF-β1) signaling, but mechanisms remain unclear.

Purpose of the Study:

  • To investigate the influence of sex hormones and sex-specific gene signatures on diabetes- and TGF-β1-induced renal damage.
  • To elucidate the complex interplay between sex, hormones, and fibrotic signaling in diabetic kidney disease.

Main Methods:

  • Utilized a db/db diabetes mouse model, ex vivo murine renal tissue, and TKPTS proximal tubular cell line.
  • Examined sex-specific changes in sex hormone concentrations and renal receptor expression.
  • Analyzed the impact of sex, hormones, and TGF-β1 on profibrotic cytokine (CTGF) expression.

Main Results:

  • Diabetes differentially affects sex hormone levels and renal receptor expression based on sex.
  • Sex, sex hormones, and diabetes modulate the expression of TGF-β1, its receptor, and BMP7.
  • Sex and sex hormones, alongside TGF-β1 levels, dictate the net outcome of CTGF expression, a key profibrotic factor.

Conclusions:

  • Complex crosstalk exists between sex hormones, sex-dependent gene expression, and profibrotic signals in diabetic nephropathy (DN) development.
  • Findings offer insights into previously contradictory results regarding sex differences in DN.
  • Understanding these sex-specific mechanisms is crucial for targeted DN therapies.